2024
Glioblastom – aktuelle Therapiekonzepte
Rieger D, Renovanz M, Kurz S, Bombach P, Paulsen F, Roder C, Tatagiba M, Niyazi M, Tabatabai G. Glioblastom – aktuelle Therapiekonzepte. Die Onkologie 2024, 30: 145-156. DOI: 10.1007/s00761-024-01473-7.Peer-Reviewed Original ResearchClinical trialsWorld Health Organization classificationCombination of radiotherapyFirst-line therapyDiagnosis of glioblastomaPatterns of disease progressionTherapeutic clinical trialsTumor Treating FieldsCurrent treatment conceptsCentral nervous systemNeuro-oncology careTemozolomide chemotherapyFirst-linePostoperative therapyPrimary neoplasmsOrganization classificationUnfavorable prognosisTumor progressionClinical statusDisease progressionTreatment conceptTreatment recommendationsBiomarker-basedNervous systemGlioblastoma
2020
Prevalence and temporal trends of prescription drug use in cancer survivors: A population study, 2001 to 2016.
Liu E, Kurz S, Ahn J, Sulman E. Prevalence and temporal trends of prescription drug use in cancer survivors: A population study, 2001 to 2016. Journal Of Clinical Oncology 2020, 38: 12023-12023. DOI: 10.1200/jco.2020.38.15_suppl.12023.Peer-Reviewed Original ResearchNational Health and Nutrition Examination SurveyPrescription drug useCancer survivorsProportions of positive depression screeningDrug useHealth and Nutrition Examination SurveyPrescription drug usagePositive depression screenTemporal trendsNutrition Examination SurveyCentral nervous systemHistory of cancerEffects of cancerUS adult populationCNS-active medicationsCross-sectional analysisDepression screeningExamination SurveyChronic conditionsYoung survivorsPrescription medicationsCancer sequelaeActive medicationAdult respondentsCancer diagnosis